Source: GWASCAT

Gene Gene Full Name DSI g DPI g pLI Disease Type Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
Entrez Id: 753
Gene Symbol: LDLRAD4
LDLRAD4 		low density lipoprotein receptor class A domain containing 4 0.769 0.231 0.62
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 5048
Gene Symbol: PAFAH1B1
PAFAH1B1 		platelet activating factor acetylhydrolase 1b regulatory subunit 1 0.504 0.769 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 4781
Gene Symbol: NFIB
NFIB 		nuclear factor I B 0.573 0.654 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 4507
Gene Symbol: MTAP
MTAP 		methylthioadenosine phosphorylase 0.514 0.731 7.6E-08
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 2104
Gene Symbol: ESRRG
ESRRG 		estrogen related receptor gamma 0.621 0.692 7.1E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 2070
Gene Symbol: EYA4
EYA4 		EYA transcriptional coactivator and phosphatase 4 0.604 0.615 4.9E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 200403
Gene Symbol: VWA3B
VWA3B 		von Willebrand factor A domain containing 3B 0.729 0.154 9.7E-28
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 20
Gene Symbol: ABCA2
ABCA2 		ATP binding cassette subfamily A member 2 0.670 0.615 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 148534
Gene Symbol: TLCD4
TLCD4 		TLC domain containing 4 0.931 0.038 0.26
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 1415
Gene Symbol: CRYBB2
CRYBB2 		crystallin beta B2 0.623 0.462 0.39
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 1305
Gene Symbol: COL13A1
COL13A1 		collagen type XIII alpha 1 chain 0.608 0.654 3.7E-14
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 11037
Gene Symbol: STON1
STON1 		stonin 1 0.729 0.308 1.5E-11
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 10659
Gene Symbol: CELF2
CELF2 		CUGBP Elav-like family member 2 0.628 0.692 1.00
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 1060
Gene Symbol: CENPC
CENPC 		centromere protein C 0.743 0.538 7.4E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 105
Gene Symbol: ADARB2
ADARB2 		adenosine deaminase RNA specific B2 (inactive) 0.716 0.308 0.86
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 2113
Gene Symbol: ETS1
ETS1 		ETS proto-oncogene 1, transcription factor 0.444 0.731 0.78
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 22871
Gene Symbol: NLGN1
NLGN1 		neuroligin 1 0.705 0.385 0.85
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 22920
Gene Symbol: KIFAP3
KIFAP3 		kinesin associated protein 3 0.760 0.346 1.6E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 387890
Gene Symbol: TMEM233
TMEM233 		transmembrane protein 233 1.000 9.1E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 3660
Gene Symbol: IRF2
IRF2 		interferon regulatory factor 2 0.575 0.769 0.80
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 30844
Gene Symbol: EHD4
EHD4 		EH domain containing 4 0.931 0.115 4.2E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 29119
Gene Symbol: CTNNA3
CTNNA3 		catenin alpha 3 0.612 0.692 1.0E-12
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 286749
Gene Symbol: STON1-GTF2A1L
STON1-GTF2A1L 		STON1-GTF2A1L readthrough 0.682 0.385 1.5E-22
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 284217
Gene Symbol: LAMA1
LAMA1 		laminin subunit alpha 1 0.582 0.808 3.2E-32
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 27165
Gene Symbol: GLS2
GLS2 		glutaminase 2 0.597 0.538 1.3E-10
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019